ADCT · ADC Therapeutics SA · Documents
$1.52
+0.08 (+5.56%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$190.22M
Shares
127.67M
Volume · Oct 20
1.06M
Avg daily vol (3M)
1.52M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | ADC Therapeutics SA entered a $86.6 million private placement, conditioned its loan amendment on $70.0 million of term-loan prepayment, and gained a royalty buyout option for $525 million through December 31, 2029, less royalties previously paid to HCR. | 2026-10-13 | 2026-10-07 | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | — | |
| 8-K | — | 2026-07-02 | 2026-06-30 | |
| 8-K | — | 2026-06-24 | — | |
| 8-K | — | 2026-06-03 | — | |
| 8-K | — | 2026-06-02 | 2026-06-01 | |
| 10-Q | — | 2026-05-04 | 2026-03-31 | |
| 8-K | — | 2026-05-04 | — | |
| DEFA14A | — | 2026-04-20 | — | |
| DEF 14A | — | 2026-04-20 | 2026-06-01 | |
| PRE 14A | — | 2026-04-10 | 2026-06-01 | |
| 8-K | — | 2026-03-10 | — | |
| ARS | — | 2026-03-10 | 2025-12-31 | |
| S-3 | — | 2026-03-10 | — | |
| 10-K | — | 2026-03-10 | 2025-12-31 | |
| 8-K | — | 2026-02-23 | 2026-02-18 | |
| 8-K | — | 2026-01-12 | — | |
| 8-K | — | 2026-01-08 | — | |
| S-3/A | — | 2025-12-09 | — | |
| 8-K | — | 2025-12-05 | 2025-12-03 | |
| 10-Q | — | 2025-11-10 | 2025-09-30 | |
| S-3 | — | 2025-11-10 | — | |
| 8-K | — | 2025-11-10 | — | |
| 8-K | — | 2025-10-14 | 2025-10-12 | |
| 8-K | — | 2025-09-30 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-08-12 | — | |
| S-3 | — | 2025-06-30 | — | |
| 8-K | — | 2025-06-12 | 2025-06-11 | |
| 8-K | — | 2025-06-05 | 2025-06-03 | |
| 10-Q | — | 2025-05-14 | 2025-03-31 | |
| 8-K | — | 2025-05-14 | — | |
| DEFA14A | — | 2025-04-21 | — | |
| DEF 14A | — | 2025-04-21 | 2025-06-03 | |
| PRE 14A | — | 2025-04-09 | 2025-06-03 | |
| ARS | — | 2025-03-27 | 2024-12-31 | |
| 8-K | — | 2025-03-27 | — | |
| 10-K | — | 2025-03-27 | 2024-12-31 | |
| 8-K | — | 2025-01-13 | — | |
| 8-K | — | 2024-11-13 | 2024-11-11 | |
| 8-K | — | 2024-11-07 | — | |
| 10-Q | — | 2024-11-07 | 2024-09-30 | |
| DEFA14A | — | 2024-09-23 | — | |
| DEF 14A | — | 2024-09-23 | 2024-11-11 | |
| PRE 14A | — | 2024-09-13 | 2024-11-11 | |
| S-3 | — | 2024-08-06 | — | |
| 8-K | — | 2024-08-06 | — | |
| 10-Q | — | 2024-08-06 | 2024-06-30 | |
| 8-K | — | 2024-06-14 | 2024-06-13 |
Showing 1–50 of 212 filings
Key facts
CIK
1771910
CUSIP
H0036K147
13F (30d)
10 filings
10 filers
Visit website
Investor relations